The Dow Jones Newswire today reports an FDA warning of a possible link between autism and Depakote, a drug used to treat seizures, migraines and bipolar manic episodes:
In a review of Depakote, the agency said it identified six reports of developmental delay in children that were not related to birth defects, including two cases of autism in one family. However, the agency said, "other factors such as genetic and environmental factors may have played a role, especially in the two sibling cases coded as autism."
Agency staff said birth defects are well described in the drug label, but said developmental delays and learning disabilities are not mentioned.
autism
No comments:
Post a Comment